Daniel Shevrin to Follow-Up Studies
This is a "connection" page, showing publications Daniel Shevrin has written about Follow-Up Studies.
Connection Strength
0.027
-
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. N Engl J Med. 2015 Aug 20; 373(8):737-46.
Score: 0.020
-
Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586). Am J Clin Oncol. 2000 Aug; 23(4):371-5.
Score: 0.007